Point‑of‑Care Testing Could Accelerate Early Detection of Chronic Kidney Disease in Africa
A 2026 systematic review found CKD affects about 13.7% of adults in 19 African countries.
In Brief
- •A 2026 systematic review found CKD affects about 13.7% of adults in 19 African countries.
- •Early detection is hampered by limited laboratory access, high costs, and gaps in routine screening.
- •Point‑of‑care testing (POCT) for creatinine and urine albumin can reduce specimen transport delays and support timely clinical decisions.
- •KDIGO 2024 guidelines and WHO’s Model List endorse POCT for CKD screening in low‑resource settings.
- •Accuracy of POCT devices varies, underscoring the need for rigorous evaluation against laboratory standards.
Why It Matters
Chronic kidney disease is a rising public‑health threat across Africa, yet many patients remain undiagnosed until advanced stages, limiting treatment options and increasing mortality. By bringing diagnostic tests closer to patients, POCT could enable earlier intervention, reduce disease progression, and alleviate the burden on centralized laboratories. The endorsement of POCT by leading bodies such as KDIGO and WHO signals a shift toward decentralized care models that could transform kidney health outcomes in underserved regions.
Key Details
- CKD Prevalence
- 13.7% of adults
- Countries Covered
- 19 African countries
- Guideline Reference
- KDIGO 2024
- WHO Inclusion
- Model List of Essential In Vitro Diagnostics
Context & Background
CKD has emerged as a growing public health concern in Africa, with early detection remaining difficult due to persistent gaps in diagnostic services and routine screening.
Original Reporting & Sources
VNews is an independent briefing product. Original reporting remains credited to the following publishers:
This brief was synthesized automatically using attributed third-party reporting. VNews is a digital news publication produced under the VContent Group brand and operated by Francis Vincent Sunday in Ghana, independent from the publishers cited above. Read our AI Transparency Policy and Editorial & Corrections Policy.